中概股 · 2026-02-04
The 'All-Encompassing' Regulatory Logic of China's New Overseas Listing Rules
The effective date of 26 March 2023 for the Trial Administrative Measures of Overseas Securities Offerings and Listings by Domestic Companies (《境内企业境外发行证券和上市管理试行办法》, hereinafter the “Measures”) and its five accompanying guidelines marked a structural break in how Beijing governs cross-border capital market access. Nearly three years on, the market has absorbed the filing-based regime, yet the regulatory logic underpinning it remains incompletely understood by many issuers and advisors. The shift from a pre-approval model—where the China Securities Regulatory Commission (CSRC) effectively vetted each overseas listing application through a case-by-case review—to a notification-plus-consistency-check framework has not reduced the substantive scope of regulatory oversight. Instead, the Measures codify a principle of “all-encompassing” (全覆盖) jurisdiction: any domestic company, regardless of its legal domicile or share structure, that seeks to list or issue securities offshore must file with the CSRC if its “principal place of business, core assets, or main source of revenue” is in mainland China. This article examines the precise mechanics of this regime, its interaction with Hong Kong’s dual-primary listing rules, and the unresolved tension between the CSRC’s extraterritorial assertion and the listing rules of the Hong Kong Exchange (HKEX) and the US Securities and Exchange Commission (SEC).
The Filing Regime: From Vetting to Notification, but with Substantive Backstops
The Measures replaced the 1994 Special Provisions of the State Council on the Issuance and Listing of Shares Overseas by Joint Stock Limited Companies and the 1997 Administrative Regulations on the Listing of Shares Overseas by Domestic Companies, which required explicit CSRC approval letters (the so-called “no-objection letter”) before any offshore listing. Under Article 2 of the Measures, the definition of a “domestic company” now includes any enterprise “directly or indirectly” controlled by a PRC resident or entity, irrespective of whether the listing vehicle is incorporated in the Cayman Islands, the British Virgin Islands, or Bermuda. This closes the loophole exploited by the pre-2023 VIE (Variable Interest Entity) structure, where offshore SPVs (Special Purpose Vehicles) were used to circumvent domestic restrictions on foreign ownership in sectors such as telecommunications, education, and internet platforms.
The filing threshold is not discretionary. Article 3 of the Measures stipulates that any overseas offering or listing by a domestic company must be filed with the CSRC within three business days of the submission of the listing application to the overseas exchange. Failure to file renders the issuance invalid and exposes the issuer to penalties under Article 27, including fines of up to RMB 10 million for the issuer and RMB 500,000 for the responsible individual. As of December 2024, the CSRC had received 287 filings from companies targeting Hong Kong’s Main Board and 43 from those targeting US exchanges (Nasdaq and NYSE), according to the CSRC’s public filing database. Of these, 19 filings were returned for supplementary information, typically relating to the identification of the ultimate beneficial owner or the legality of the VIE structure under PRC foreign investment laws.
The consistency check is the real gatekeeper. While the filing process is nominally a notification, the CSRC retains the power to review the prospectus or listing document for consistency with PRC laws and regulations. Article 11 of the Measures requires that the filing materials include a legal opinion from a PRC-licensed law firm confirming that the offering complies with the Foreign Investment Law of the People’s Republic of China (2019), the Cybersecurity Law (2017), and the Data Security Law (2021). For companies in sectors subject to foreign investment restrictions—such as value-added telecommunications services under the Special Administrative Measures (Negative List) for Foreign Investment Access (2024 edition)—the opinion must specifically address whether the VIE structure violates the negative list. This has created a de facto substantive review for companies in sensitive industries, even though the CSRC does not issue an explicit “approval” letter.
Hong Kong as the Primary Testing Ground for the New Regime
Hong Kong remains the dominant destination for PRC-incorporated or PRC-controlled issuers, accounting for 84% of all CSRC filings in 2024 (241 out of 287). The interaction between the CSRC filing regime and the HKEX Listing Rules has produced a dual-layer compliance burden that issuers must navigate sequentially, not simultaneously.
The HKEX’s Chapter 19C and Chapter 8A rules for overseas issuers. Under HKEX Listing Rule 19C.06, an overseas issuer seeking a primary listing on the Main Board must demonstrate that its home jurisdiction (the jurisdiction of incorporation) provides investor protections at least equivalent to those in Hong Kong. For Cayman-incorporated vehicles—the standard structure for PRC issuers—this equivalence is generally assumed, but the CSRC filing adds a second jurisdictional overlay. The HKEX’s Guidance Letter GL94-18 (updated in March 2023) explicitly requires that a listing applicant confirm it has filed with the CSRC (or can demonstrate that it is exempt) before the HKEX will process the listing application. This creates a sequencing problem: the issuer must file with the CSRC before the HKEX formally accepts the application, but the CSRC filing itself requires a near-final draft of the prospectus, which cannot be finalised until the HKEX provides initial comments. Practitioners report that this circular dependency typically adds 4-6 weeks to the listing timeline.
The dual-primary and secondary listing distinction matters. For companies already listed on a US exchange that seek a secondary listing in Hong Kong under Chapter 19C, the CSRC filing requirement applies only to the new offering, not to the existing US listing. However, if the company converts its secondary listing to a dual-primary listing—as did Alibaba Group Holding Limited (9988.HK) in August 2024—the CSRC must be notified of the conversion, and the company must submit a supplementary filing under Article 14 of the Measures. This is because a dual-primary listing involves the issuance of new shares in Hong Kong, which triggers the filing requirement anew. The CSRC’s response to Alibaba’s conversion, published on its website on 28 August 2024, confirmed that the filing was “accepted as complete,” but the regulator noted that it retained the right to request additional information within 30 business days—a period that expired without further action, indicating tacit approval.
The VIE structure remains permissible but subject to heightened scrutiny. Contrary to market speculation in 2022-2023 that the CSRC would ban VIE structures outright, the Measures do not prohibit them. Instead, Article 8 of the Measures requires that the filing materials include a detailed explanation of the VIE arrangement, including the contractual controls, the profit-sharing mechanism, and the risk of PRC regulatory intervention. The CSRC’s Guideline No. 2 on the Content and Format of Filing Documents (March 2023) further specifies that the legal opinion must opine on whether the VIE structure contravenes the Negative List. In practice, this has led to a bifurcation: VIE structures in sectors explicitly prohibited to foreign investment (e.g., internet news services) are effectively blocked, while those in restricted sectors (e.g., value-added telecommunications) are permitted but subject to enhanced disclosure. As of end-2024, the CSRC had accepted filings from 17 companies using VIE structures, all of which were in the latter category.
US Listings Under the New Regime: The Audit Act Overlay
The CSRC filing regime for US-bound issuers operates in parallel with the Holding Foreign Companies Accountable Act (HFCAA, effective 2020) and its implementing rules under the SEC. The interaction creates a compliance matrix that is more onerous than either regime individually.
The CSRC filing does not exempt issuers from PCAOB inspection. Under Article 23 of the Measures, the CSRC may share filing materials with overseas regulators on a reciprocal basis, but it does not waive PRC confidentiality laws. This creates a tension with the Public Company Accounting Oversight Board (PCAOB) requirement under the HFCAA that audit firms must allow PCAOB inspection of their working papers. The 2022 agreement between the PCAOB and the CSRC (the Protocol for Inspections and Investigations of Audit Firms Based in Mainland China and Hong Kong) resolved the immediate standoff, allowing PCAOB access to audit workpapers stored in mainland China. However, the agreement is subject to annual renewal, and the CSRC retains the right to redact information that it deems to implicate “national security” under the Data Security Law. This uncertainty has not prevented 43 Chinese companies from listing in the US in 2024, but it has increased the cost of compliance: audit fees for US-bound Chinese issuers rose by an average of 35% year-on-year in 2024, according to data from the China Securities Journal.
The SEC’s enhanced disclosure rules on VIE and PRC government control. In November 2023, the SEC adopted final rules requiring all foreign issuers to disclose whether their corporate structure includes VIE arrangements and to specify the extent of PRC government control over their operations (SEC Release No. 33-11264). This rule applies to any issuer that files a registration statement under the Securities Act of 1933 or the Securities Exchange Act of 1934. For a Chinese company filing with the CSRC under the Measures, the SEC disclosure must be consistent with the CSRC filing—any discrepancy could trigger an SEC comment letter or, in extreme cases, a suspension of trading. This creates a single factual record that must satisfy two regulators with different definitions of “control” and “ownership.” The CSRC defines “control” under Article 2 of the Measures as the power to direct the management and policies of an enterprise, while the SEC uses the accounting definition under ASC 810-10-15. These definitions are not identical, and reconciling them has become a standard item in US counsel’s due diligence checklists.
The delisting risk remains real but diminished. The HFCAA required the SEC to identify issuers whose audit firms were not subject to PCAOB inspection for three consecutive years. As of the SEC’s most recent list (published 10 December 2024), no Chinese company was on the “conclusive” delisting list, down from a peak of 275 companies in December 2022. This reflects the PCAOB’s successful inspection of mainland Chinese and Hong Kong audit firms in 2023 and 2024. However, the CSRC’s 2024 annual work report, published in January 2025, noted that it had “strengthened the review of cross-border data transfers” and that it would “continue to assess the national security implications of audit workpaper access.” Any tightening of this stance could reintroduce the delisting risk for US-listed Chinese companies.
The Unresolved Jurisdictional Tension and Practical Implications
The “all-encompassing” logic of the Measures creates a fundamental jurisdictional tension: the CSRC asserts authority over companies that are incorporated outside the PRC, whose shares trade on exchanges outside the PRC, and whose investors are primarily outside the PRC. This extraterritorial assertion is not unique—the US SEC and the EU’s European Securities and Markets Authority (ESMA) have similar reach under their respective laws—but the PRC regime is distinctive in its breadth and in the absence of a clear statutory basis for the assertion.
The legal basis is the Securities Law of the People’s Republic of China (2019 revision), Article 224. This article states that “the securities regulatory authority of the State Council may, in accordance with the provisions of the State Council, formulate specific measures for the overseas listing and issuance of securities by domestic companies.” The Measures are the implementation of this enabling provision. However, Article 224 does not explicitly authorise the CSRC to regulate offshore vehicles controlled by PRC residents—it only references “domestic companies.” The Measures’ definition of “domestic company” to include offshore entities is an administrative interpretation that has not been tested in a PRC court. In a 2024 opinion article published in the Journal of Financial Regulation (Vol. 12, No. 3), Professor Zhang Wei of Peking University Law School argued that the CSRC’s interpretation “strains the plain language of Article 224” and that a legislative amendment would be required to provide a firmer constitutional footing. No such amendment has been proposed.
The practical consequence is a heightened compliance burden for dual-listed companies. A company that lists both in Hong Kong and the US—such as JD.com Inc. (9618.HK, JD.US) or NetEase Inc. (9999.HK, NTES.US)—must comply with the CSRC filing regime, the HKEX Listing Rules, the SEC’s disclosure rules, and the PCAOB’s inspection requirements. The filing obligations are not coordinated: the CSRC requires a separate filing for each jurisdiction, even if the offering is concurrent. For JD.com’s secondary listing in Hong Kong in 2020 (pre-Measures), no CSRC filing was required. For any future follow-on offering by JD.com, the CSRC filing would be mandatory, and the company would need to reconcile its US and Hong Kong disclosure documents with the CSRC filing—a process that the company’s 2024 annual report (Form 20-F, filed 15 April 2024) describes as “time-consuming and costly, and may result in delays or additional regulatory scrutiny.”
The regime is still evolving. In November 2024, the CSRC published a consultation draft of amendments to the Measures, proposing to extend the filing requirement to any “offshore fundraising by a domestic company, including private placements and convertible bond issuances” (Article 2, draft amendment). If adopted, this would capture transactions that are currently outside the filing regime, such as a private placement of convertible notes by a Cayman-incorporated PRC tech company to a US institutional investor. The consultation period closed on 31 December 2024, and the final amendments are expected in Q2 2025. Market participants should monitor this closely.
Actionable Takeaways
-
File early, not late: The CSRC filing must be submitted within three business days of the overseas exchange application, but the filing materials require a near-final prospectus—plan for a 4-6 week lead time to prepare the legal opinion and VIE disclosure, and budget for potential supplementary information requests that can add 30-60 days.
-
Reconcile definitions of “control” across jurisdictions: The CSRC’s administrative control definition under the Measures, the SEC’s accounting control definition under ASC 810, and the HKEX’s de facto control standard under Listing Rule 19C.06 are not identical—engage separate PRC, US, and Hong Kong counsel to produce a single factual matrix that satisfies all three.
-
Assume VIE structures are permissible but require full transparency: The CSRC has not banned VIE structures, but any VIE in a sector on the Negative List (2024 edition) must be accompanied by a legal opinion confirming compliance—expect this to be the most scrutinised part of the filing and prepare for CSRC follow-up questions on profit repatriation and control rights.
-
Monitor the PCAOB-CSRC agreement renewal cycle: The current protocol expires in December 2025—any change in the CSRC’s stance on data transfer could revive delisting risk for US-listed Chinese companies, making Hong Kong dual-primary listing a prudent insurance policy for issuers with a US listing.
-
Prepare for the expanded filing scope in Q2 2025: The proposed amendment to include private placements and convertible bonds would capture transactions currently outside the regime—any offshore fundraising by a PRC-controlled company, regardless of structure, should be structured with the assumption that a CSRC filing will be required.